| Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD (NCT05436210) | Hacettepe University | 2022-06-23 |
| Motor Imagery in Duchenne Muscular Dystrophy (NCT05559710) | Hacettepe University | 2022-06-20 |
| Schulze Muscular Dystrophy Ability Clinical Study (NCT05409079) | AbiliTech Medical Inc. | 2022-05-26 |
| Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions (NCT05661071) | Hacettepe University | 2022-05-11 |
| Bicycle Ergometer Training in Duchenne Muscular Dystrophy (NCT05330195) | Hacettepe University | 2022-04-18 |
| Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy (NCT05280730) | Virginia Commonwealth University | 2022-02-02 |
| Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD) (NCT05338099) | ENCell | 2022-01-18 |
| Tadalafil as Adjuvant Therapy for DMD (NCT05195775) | University of Florida | 2021-12-14 |
| Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices (NCT05110885) | Bahçeşehir University | 2021-11-01 |
| A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (NCT05096221) | Sarepta Therapeutics, Inc. | 2021-10-27 |
| Brain Involvement in Dystrophinopathies Part 2 (NCT04668716) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2021-10-11 |
| Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital (NCT05029232) | Sohag University | 2021-10-01 |
| Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy (NCT05464446) | Lokman Hekim University | 2021-10-01 |
| Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor (NCT04335942) | Assistance Publique - Hôpitaux de Paris | 2021-09-30 |
| CureDuchenne Link®: A Resource for Research (NCT04972604) | CureDuchenne | 2021-07-09 |
| Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53) (NCT04956289) | NS Pharma, Inc. | 2021-07-01 |
| Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) (NCT04687020) | NS Pharma, Inc. | 2021-06-10 |
| Once Weekly Infant Corticosteroid Trial for DMD (NCT05412394) | Anne M. Connolly | 2021-04-30 |
| Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) (NCT04768062) | NS Pharma, Inc. | 2021-04-13 |
| The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy (NCT04782440) | Marmara University | 2021-04-01 |
| Brain Involvement in Dystrophinopathies Part 1 (NCT04583917) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2021-03-30 |
| Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD (NCT04632940) | Kyntra Bio | 2021-03-03 |
| Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy (NCT04529707) | University of Pittsburgh | 2021-02-17 |
| Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD) (NCT05564962) | Hacettepe University | 2021-01-19 |
| Telerehabilitation in Duchenne Muscular Dystrophy (NCT05305976) | Karadeniz Technical University | 2021-01-11 |
| Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy (NCT06103006) | Lokman Hekim University | 2021-01-01 |
| A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort (NCT04626674) | Sarepta Therapeutics, Inc. | 2020-11-23 |
| Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy (NCT04281485) | Pfizer | 2020-11-05 |
| A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） (NCT04587908) | Taiho Pharmaceutical Co., Ltd. | 2020-11-01 |
| An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy (NCT04708314) | Rare Disease Research, LLC | 2020-10-31 |
| Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy (NCT01484678) | University of Florida | 2020-09-01 |
| Physical Activity Level of Norwegian Boys with Duchenne Muscular Dystrophy (NCT03947112) | Haukeland University Hospital | 2020-08-20 |
| Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) (NCT04371666) | Kyntra Bio | 2020-08-10 |
| Open-label Extension of the HOPE-2 Trial (NCT04428476) | Capricor Inc. | 2020-08-05 |
| Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study (NCT05982119) | Centre Hospitalier Universitaire de Liege | 2020-07-10 |
| Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy (NCT04433234) | Daiichi Sankyo Co., Ltd. | 2020-06-30 |
| Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) (NCT04060199) | NS Pharma, Inc. | 2020-04-14 |
| A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. (NCT04179409) | Kevin Flanigan | 2020-02-18 |
| Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy (NCT05244395) | Hacettepe University | 2020-02-10 |
| AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. (NCT04240314) | Megan Waldrop | 2020-01-15 |
| Natural History of Duchenne Muscular Dystrophy (NCT03882827) | Genethon | 2019-12-19 |
| Exploratory Study of NS-089/NCNP-02 in DMD (NCT04129294) | National Center of Neurology and Psychiatry, Japan | 2019-12-02 |
| Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy (NCT05016908) | Massachusetts General Hospital | 2019-11-30 |
| Wearable Technology to Assess Gait Function in SMA and DMD (NCT04193085) | Columbia University | 2019-11-25 |
| Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (NCT03907072) | Wave Life Sciences USA, Inc. | 2019-09-04 |
| A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy (NCT03760029) | Pfizer | 2019-07-24 |
| A Registered Cohort Study on Duchenne Muscular Dystrophy (NCT04012671) | Ning Wang, MD., PhD. | 2019-07-01 |
| Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (NCT04004065) | Sarepta Therapeutics, Inc. | 2019-06-26 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) (NCT03985878) | Sarepta Therapeutics, Inc. | 2019-06-26 |
| The Burden of Access in Duchenne Muscular Dystrophy in the US (NCT03951675) | University of Florida | 2019-06-18 |
| Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy (NCT03936894) | Children's National Research Institute | 2019-05-01 |
| A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren (NCT03796637) | PTC Therapeutics | 2019-04-11 |
| Aerobic Exercise in Duchenne Muscular Dystrophy (NCT04173234) | Hacettepe University | 2019-04-11 |
| The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy (NCT04287582) | Hacettepe University | 2019-04-03 |
| Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease (NCT04120168) | Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition | 2019-04-01 |
| Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy (NCT05274555) | Dokuz Eylul University | 2019-03-27 |
| An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (NCT03917719) | Catabasis Pharmaceuticals | 2019-03-14 |
| Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback (NCT03689660) | Merve Kurt | 2019-02-01 |
| Bisoprolol in DMD Early Cardiomyopathy (NCT03779646) | Peking Union Medical College Hospital | 2019-01-16 |
| A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice (NCT06606340) | Sarepta Therapeutics, Inc. | 2019-01-07 |
| A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) (NCT03648827) | PTC Therapeutics | 2018-12-21 |
| Parent and Infant Inter(X)Action Intervention (PIXI) (NCT03836300) | RTI International | 2018-11-30 |
| A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD) (NCT03642145) | PTC Therapeutics | 2018-10-31 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM. (NCT03513367) | University Hospital, Toulouse | 2018-09-19 |
| Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD (NCT03531788) | Roxanna Marie Bendixen | 2018-08-30 |
| Biomarker for Duchenne Muscular Dystrophy (NCT02994030) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Safety and Efficacy of P-188 NF in DMD Patients (NCT03558958) | Phrixus Pharmaceuticals, Inc. | 2018-08-08 |
| Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device (NCT03611244) | Seoul National University Hospital | 2018-08-07 |
| An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy (NCT03532542) | Sarepta Therapeutics, Inc. | 2018-08-02 |
| Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) (NCT03603288) | Santhera Pharmaceuticals | 2018-07-04 |
| A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03439670) | ReveraGen BioPharma, Inc. | 2018-06-29 |
| Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) (NCT06304064) | Capricor Inc. | 2018-06-21 |
| Tamoxifen in Duchenne Muscular Dystrophy (NCT03354039) | University Hospital, Basel, Switzerland | 2018-06-12 |
| Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography (NCT03490214) | University of Erlangen-Nürnberg Medical School | 2018-06-01 |
| Relationship Between PFTs and Pdi in DMD (NCT03335384) | University of Minnesota | 2018-05-01 |
| UTSW HP [13-C] Pyruvate Injection in HCM (NCT03057002) | University of Texas Southwestern Medical Center | 2018-05-01 |
| Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy (NCT03507530) | Canan İpek | 2018-04-01 |
| Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy (NCT03589612) | Hacettepe University | 2018-03-08 |
| Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy (NCT03508947) | Wave Life Sciences USA, Inc. | 2018-01-24 |
| A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy (NCT03362502) | Pfizer | 2018-01-23 |
| A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (NCT03375164) | Sarepta Therapeutics, Inc. | 2018-01-04 |
| Prognostic Factors Affecting Duchenne Muscular Dystrophy (NCT03372655) | Assiut University | 2018-01-01 |
| Microdystrophin Gene Transfer Study in Adolescents and Children With DMD (NCT03368742) | Solid Biosciences Inc. | 2017-12-06 |
| Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy (NCT03333590) | Kevin Flanigan | 2017-11-06 |
| Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study (NCT03373968) | Italfarmaco | 2017-10-24 |
| Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03319030) | Ann & Robert H Lurie Children's Hospital of Chicago | 2017-09-01 |
| Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping (NCT03218995) | Sarepta Therapeutics, Inc. | 2017-08-16 |
| Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03167255) | NS Pharma, Inc. | 2017-07-06 |
| Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy (NCT03039686) | Hoffmann-La Roche | 2017-07-06 |
| Duchenne Muscular Dystrophy Heart Study (NCT03443115) | Hôpital Cochin | 2017-06-27 |
| Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption (NCT03529240) | Hacettepe University | 2017-06-10 |
| The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy (NCT03541070) | Hacettepe University | 2017-06-10 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy (NCT02851797) | Italfarmaco | 2017-06-06 |
| Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy (NCT03521271) | Hacettepe University | 2017-04-05 |
| Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy (NCT03589573) | Hacettepe University | 2017-03-24 |
| Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03038399) | ReveraGen BioPharma, Inc. | 2017-02-02 |
| Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy (NCT03552874) | Hacettepe University | 2017-01-01 |
| Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance (NCT03534349) | Hacettepe University | 2017-01-01 |
| Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) (NCT02740972) | NS Pharma, Inc. | 2016-12-01 |